title: [Therapy of purulent meningitis with immunglobulins] (author's transl)].
abstract: The finding of 53% disturbances in synthesizing bacterial antibodies and 88% disturbances in opsonizing in children with purulent meningitis was the reason for therapy with immunglobulins. Intravenous Gammaglobulin (Gammavenin) was used in 26 children with purulent meningitis, 1 ml/kg/d through 3 days. The liquor cell count was in all patients 48 hours after starting of treatment 20% or less, there was no death, 2 children showed neurological defects.
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008581:Meningitis / Q000188:drug therapy*; D005719:gamma-Globulins / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D005719:gamma-Globulins
vernacular_title: Therapie der eitrigen meningitis mit immunglobulin.